The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk of contracting MDR-TB in children younger than 5 who had a household exposure. This is one of the first successful trials for prevention of MDR-TB. Read more here.
top of page
Recent Posts
See AllA new study revealed that resistance is developing to the 6-month BPaLM regimen recommended by the WHO. The study investigated around...
70
Preliminary findings from the phase 1B PanACEA trial shows promising results for a new antibiotic, BTZ-043. The aim is to create an...
10
A new initiative in Nigeria aims to provide state health insurance to any patient with drug resistant TB in the country. Implementation...
40
bottom of page
Comments